Anti-annexin V IgM and IgG autoantibodies and the risk of idiopathic recurrent spontaneous miscarriage

Journal of Reproductive Immunology

Volumn 89, Issue 1, 2011, Pages 78-83

  Sater, Mai S ^a   Finan, Ramzi R ^b   Mustafa, Fekria E ^a   Al Khateeb, Ghada M ^a   Almawi, Wassim Y ^a  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

^b SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

Anti annexin v antibodies; Pregnancy; Recurrent miscarriage; Thrombosis

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOCORTIN 5;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIPARA; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; ANNEXIN A5; AUTOANTIBODIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEBANON; PREGNANCY; PROGNOSIS; RISK FACTORS;

EID: 79954986234     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2010.12.009     Document Type: Article

References (34)

1. Alijotas-Reig J., Ferrer-Oliveras R., Rodrigo-Anoro M.J., Farran-Codina I., Llurba-Olivé E., Vilardell-Tarres M., Casellas-Caro M. Anti-annexin A5 antibodies in women with spontaneous pregnancy loss. Med. Clin. (Barc). 2010, 134:433-438.
2. Andree H.A.M., Hermens W.T., Hemker H.C., Willems G.M. Displacement of factor Va by annexin V. Phospholipid Binding and Anticoagulant Action of Annexin V 1992, 73. Universitaire pers Maastricht, Maastricht, the Netherlands. H.A.M. Andree (Ed.).
3. Armstrong B.G., McDonald A.D., Sloan M. Cigarette, alcohol, and coffee consumption and spontaneous abortion. Am. J. Public Health 1992, 82:85-87.
4. Arnold J., Holmes Z., Pickering W., Farmer C., Regan L., Cohen H. Anti-beta 2 glycoprotein 1 and anti-annexin V antibodies in women with recurrent miscarriage. Br. J. Haematol. 2001, 113:911-914.
5. Bizzaro N., Antico A., Musso M., Platzgummer S., Camogliano L., Tozzoli R., Villalta D. A prospective study of 1038 pregnancies on the predictive value of anti-annexin V antibodies for fetal loss. Ann. N. Y. Acad. Sci. 2005, 1050:348-356.
6. Bogdanova N., Horst J., Chlystun M., Croucher P.J., Nebel A., Bohring A., Todorova A., Schreiber S., Gerke V., Krawczak M., Markoff A. A common haplotype of the annexin A5 (ANXA5) gene promoter is associated with recurrent pregnancy loss. Hum. Mol. Genet. 2007, 16:573-578.
7. Davis E., Olson C. Obesity in pregnancy. Prim. Care 2009, 36:341-356.
8. Di Simone N., Castellani R., Caliandro D., Caruso A. Monoclonal anti-annexin V antibody inhibits trophoblast gonadotrophin secretion and induces syncytiotrophoblast apoptosis. Biol. Reprod. 2001, 65:1766-1770.
9. Farquharson R.G., Quenby S., Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet. Gynecol. 2002, 100:408-413.
10. Flaherty M.J., West S., Heimark R.L. Placental anticoagulant protein I: measurement in extracellular fluids and cells of the hemostatic system. J. Lab. Clin. Med. 1990, 115:174-179.
11. Gaspersic N., Ambrozic A., Bozic B., Majhenc J., Svetina S., Rozman B. Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-beta2-glycoprotein I and anti-annexin A5 antibodies. Rheumatology (Oxford) 2007, 46:81-86.
12. Gris J.C., Perneger T.V., Quere I., Mercier E., Fabbro-Peray P., Lavigne-Lissalde G., Hoffet M., Dechaud H., Boyer J.C., Ripart-Neveu S., et al. Antiphospholipid/antiprotein antibodies, hemostasis-related autoantibodies, and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case-control study. Blood 2003, 102:3504-3513.
13. Huang X., Ding W.Q., Vaught J.L., Wolf R.F., Morrissey J.H., Harrison R.G., Lind S.E. A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties. Blood 2006, 107:980-986.
14. Kaetzel M.A., Hazarika P., Dedman J.R. Differential tissue expression of three 35-kDa annexin calcium-dependent phospholipid-binding proteins. J. Biol. Chem. 1989, 264:14463-14470.
15. Krikun G., Lockwood C.J., Wu X.X., Zhou X.D., Guller S., Calandri C., Guha A., Nemerson Y., Rand J.H. The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalisation and in vitro regulation. Placenta 1994, 15:601-612.
16. Levine J.S., Branch D.W., Rauch J. The antiphospholipid syndrome. N. Engl. J. Med. 2002, 346:752-763.
17. Matsubayashi H., Arai T., Izumi S., Sugi T., McIntyre J.A., Makino T. Anti-annexin V antibodies in patients with early pregnancy loss or implantation failures. Fertil. Steril. 2001, 76:694-699.
18. Mbugua Gitau G., Liversedge H., Goffey D., Hawton A., Liversedge N., Taylor M. The influence of maternal age on the outcomes of pregnancies complicated by bleeding at less than 12weeks. Acta Obstet. Gynecol. Scand. 2009, 88:116-118.
19. Metwally M., Saravelos S.H., Ledger W.L., Li T.C. Body mass index and risk of miscarriage in women with recurrent miscarriage. Fertil. Steril. 2010, 94:290-295.
20. Miller M.A., Strazzullo P., Karanam S., Cappuccio F.P. Ethnic variation in levels of circulating IgG autoantibodies to oxidised low-density lipoprotein. Atherosclerosis 2009, 203:126-136.
21. Norwitz E.R., Schust D.J., Fisher S.J. Implantation and the survival of early pregnancy. N. Engl. J. Med. 2001, 345:1400-1408.
22. Pfeiffer K.A., Fimmers R., Engels G., van der Ven H., van der Ven K. The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion. Mol. Hum. Reprod. 2001, 7:373-378.
23. Quenby S., Farquharson R.G., Dawood F., Hughes A.M., Topping J. Recurrent miscarriage and long-term thrombosis risk: a case-control study. Hum. Reprod. 2005, 20:1729-1732.
24. Rand J.H., Wu X.X., Guller S., Gil J., Guha A., Scher J., Lockwood C.J. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am. J. Obstet. Gynecol. 1994, 171:1566-1572.
25. Rand J.H., Wu X.X., Andree H.A.M., Lockwood C.J., Guller S., Scher J. Pregnancy loss in the antiphospholipid-antibody syndrome: a possible thrombogenic mechanism. N. Engl. J. Med. 1997, 337:154-160.
26. Romisch J., Seiffge D., Reiner G., Paques E.P., Heimburger N. In vivo antithrombotic potency of placenta protein 4 (annexin V). Thromb. Res. 1991, 61:93-104.
27. Sangha K.K., Stephenson M.D., Brown C.J., Robinson W.P. Extremely skewed X-chromosome inactivation is increased in women with recurrent spontaneous abortion. Am. J. Hum. Genet. 1999, 65:913-917.
28. Siaka C., Lambert M., Caron C., Amiral J., Hachulla E., Hatron P.Y., Goudemand J. Low prevalence of anti-annexin V antibodies in antiphospholipid syndrome with fetal loss. Rev. Med. Interne 1999, 20:762-765.
29. Sierra S., Stephenson M. Genetics of recurrent pregnancy loss. Med. Semin. Reprod. 2006, 24:17-24.
30. Temple R., Aldridge V., Greenwood R., Heyburn P., Sampson M., Stanley K. Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study. BMJ 2002, 325:1275-1276.
31. Uthman I., Khamashta M. Ethnic and geographical variation in antiphospholipid (Hughes) syndrome. Ann. Rheum. Dis. 2005, 64:1671-1676.
32. Wang X., Campos B., Kaetzel M.A., Dedman J.R. Annexin V is critical in the maintenance of murine placental integrity. Am. J. Obstet. Gynecol. 1999, 180:1008-1016.
33. Zammiti W., Mtiraoui N., Kallel C., Mercier E., Almawi W.Y., Mahjoub T. A case-control study on the association of idiopathic recurrent pregnancy loss with autoantibodies against beta2-glycoprotein I and annexin V. Reproduction 2006, 131:817-822.
34. Zammiti W., Mtiraoui N., Finan R.R., Almawi W.Y., Mahjoub T. Tumor necrosis factor α and lymphotoxin α haplotypes in idiopathic recurrent pregnancy loss. Fertil. Steril. 2009, 91:1903-1908.